ADHD, Depression, and Bipolar Disorder: Why Symptoms Overlap and Diagnosis Can Change Over Time in Reno, Nevada
By: VitaNova Psychiatry & Wellness
Introduction: Is It ADHD, Depression, Bipolar Disorder—or a Shared Vulnerability?
Many people search for answers because their symptoms do not fit neatly into one box. They may have lifelong distractibility, emotional reactivity, periods of depression, sleep disruption, racing thoughts, low motivation, impulsivity, or burnout.
The question becomes: Are ADHD, major depressive disorder, and bipolar disorder completely separate illnesses—or can one vulnerability show up differently over time?
The current literature suggests the answer is both: these are still clinically meaningful diagnoses, but they also share genetic, neurodevelopmental, and emotional-regulation pathways that can make symptoms overlap. Large genetic studies show substantial shared genetic architecture across psychiatric disorders, challenging strict diagnostic boundaries. (Nature)
What Is Heterotypic Continuity?
Heterotypic continuity means the same underlying vulnerability may appear as different symptoms or diagnoses across development.
For example:
A child may present with ADHD symptoms → an adolescent may develop depression → an adult may later show bipolar-spectrum symptoms.
That does not mean ADHD “turns into” bipolar disorder. It means shared vulnerabilities—genetics, emotional dysregulation, sleep/circadian disruption, trauma exposure, substance use, stress load, and reward-system sensitivity—can shape how symptoms appear over time. Reviews of lifespan psychopathology describe this pattern as common across mental health conditions. (PMC)
ADHD and Mood Disorders: Why They Overlap
ADHD is not just an attention disorder. It often involves:
Emotional impulsivity
Reward sensitivity
Low frustration tolerance
Sleep problems
Executive dysfunction
Difficulty regulating motivation
Major depression can also cause poor concentration, low motivation, fatigue, indecision, and slowed thinking. Bipolar disorder can include distractibility, impulsivity, racing thoughts, decreased sleep, agitation, and emotional intensity.
That is why diagnosis requires a timeline, not just a symptom checklist.
The Genetic Vulnerability: What the Literature Says
Psychiatric genetics increasingly supports a shared-risk model. ADHD, MDD, and bipolar disorder are all polygenic, meaning risk is influenced by many genetic variants rather than one single “gene.” Recent cross-disorder studies show meaningful genetic overlap among ADHD, bipolar disorder, and major depression. (PMC)
A 2025 large-scale genetic mapping study across 14 psychiatric disorders found high levels of comorbidity and genetic overlap, supporting the idea that psychiatric conditions are not always biologically isolated categories. (Nature)
Clinically, this means a family history of ADHD, depression, bipolar disorder, substance use, or anxiety may all matter when evaluating current symptoms.
Are These Discrete Illnesses or Dimensional Conditions?
The most honest answer: both frameworks matter.
DSM diagnoses are useful because they guide treatment, billing, safety assessment, and medication decisions. But biologically, mental health conditions often behave more dimensionally.
Frameworks like the Hierarchical Taxonomy of Psychopathology (HiTOP) argue that psychiatric symptoms cluster across broader dimensions, such as internalizing symptoms, externalizing symptoms, thought disorder, and dysregulated mood. HiTOP was developed partly because traditional categories struggle with comorbidity, overlapping symptoms, and diagnostic instability. (PMC)
So, ADHD, MDD, and bipolar disorder are not “fake categories.” But they may not be fully separate biological islands either.
ADHD vs. Bipolar Disorder: The Timeline Matters
A major clinical distinction is trait-like vs. episodic symptoms.
ADHD symptoms are usually chronic and begin early in life. Bipolar symptoms are episodic and represent a noticeable change from baseline.
ADHD pattern:
Symptoms are usually present since childhood and relatively consistent across time.
Bipolar pattern:
Symptoms come in episodes—periods of elevated, expansive, or irritable mood with changes in sleep, energy, impulsivity, speech, and behavior.
A 2025 review notes that ADHD and bipolar disorder are frequently comorbid, with overlapping symptoms complicating diagnosis, but the course, timing, and episodic nature of symptoms help differentiate them. (PMC)
ADHD vs. Depression: Concentration Is Not Enough
Poor focus does not automatically mean ADHD.
Depression can cause:
Low motivation
Slowed processing
Brain fog
Fatigue
Poor memory
Reduced pleasure or reward response
ADHD tends to show earlier onset, chronic executive dysfunction, distractibility, and task-initiation problems even when mood is stable.
A recent review on adult ADHD and comorbid depressive disorders emphasizes that ADHD and depression commonly co-occur and may share etiologic pathways, but careful assessment is needed because symptoms can imitate each other. (PMC)
Why This Matters for Treatment
Misdiagnosis can change outcomes.
If bipolar disorder is missed and treated as depression alone, antidepressants may worsen activation, insomnia, agitation, or cycling in vulnerable patients. If ADHD is missed, patients may be treated repeatedly for “motivation problems” without addressing executive dysfunction. If depression is missed, stimulant treatment alone may not resolve the core mood disorder.
The goal is not to force one label. The goal is to understand the full pattern.
What a Good Psychiatric Evaluation Should Ask
A strong assessment should look at:
Childhood symptoms
Family history of ADHD, bipolar disorder, depression, suicide, or substance use
Sleep patterns
Episodic vs. chronic symptoms
Antidepressant activation history
Substance use
Trauma history
Hormonal/metabolic factors
Functional impairment over time
This is where precision psychiatry matters: the diagnosis should evolve as more information becomes clear.
Final Thoughts
The literature increasingly supports a model where ADHD, depression, and bipolar disorder can overlap through shared genetic vulnerability, emotional dysregulation, reward-system differences, and developmental pathways.
They are not always cleanly separate. They are also not all the same condition.
For patients in Reno, Nevada, the key is getting an evaluation that looks beyond a checklist and asks:
What has been present since childhood? What is episodic? What is inherited? What changed over time? And what treatment actually fits the pattern?
Call to Action
If you have been told you have ADHD, depression, bipolar disorder—or you feel like your diagnosis keeps changing—VitaNova Psychiatry & Wellness can help clarify the bigger picture.
📩 support@vitanovapsychiatryandwellness.com
🌐 vitanovapsychiatryandwellness.com
References (APA 7th Edition)
Faraone, S. V., & Larsson, H. (2023). Genetics of attention deficit hyperactivity disorder. Molecular Psychiatry, 28(3), 1074–1087. https://doi.org/10.1038/s41380-022-01623-1
Faraone, S. V., Banaschewski, T., Coghill, D., et al. (2021). The World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorder. Neuroscience & Biobehavioral Reviews, 128, 789–818. https://doi.org/10.1016/j.neubiorev.2021.01.022
Goodday, S. M., Atkinson, L., & Schaefer, J. D. (2023). Heterotypic continuity in psychopathology across development: A review of longitudinal evidence. Annual Review of Clinical Psychology, 19, 289–315. https://doi.org/10.1146/annurev-clinpsy-072720-020341
Lee, P. H., Anttila, V., Won, H., et al. (2019). Genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders. Cell, 179(7), 1469–1482.e11. https://doi.org/10.1016/j.cell.2019.11.020
McIntyre, R. S., Alda, M., Baldessarini, R. J., et al. (2020). The clinical characterization of the adult patient with ADHD and comorbid bipolar disorder. Bipolar Disorders, 22(7), 658–669. https://doi.org/10.1111/bdi.12963
Musliner, K. L., Mortensen, P. B., McGrath, J. J., et al. (2020). Association of polygenic liabilities for major depression, bipolar disorder, and schizophrenia with risk for depression in the Danish population. JAMA Psychiatry, 77(5), 516–525. https://doi.org/10.1001/jamapsychiatry.2019.4187
Nigg, J. T., Karalunas, S. L., Feczko, E., et al. (2020). Toward a revised nosology for attention-deficit/hyperactivity disorder. Biological Psychiatry, 87(4), 315–323. https://doi.org/10.1016/j.biopsych.2019.06.029
Stahl, S. M. (2021). Stahl’s essential psychopharmacology: Neuroscientific basis and practical applications (5th ed.). Cambridge University Press.
van Os, J., Guloksuz, S., Vijn, T. W., et al. (2019). The evidence-based group-level symptom-reduction model as the organizing principle for mental health care: Time for change? World Psychiatry, 18(1), 88–96. https://doi.org/10.1002/wps.20611
Widiger, T. A., & Oltmanns, J. R. (2022). The Hierarchical Taxonomy of Psychopathology (HiTOP): A dimensional alternative to traditional nosologies. Annual Review of Clinical Psychology, 18, 477–503. https://doi.org/10.1146/annurev-clinpsy-072720-014927
